These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15660059)

  • 1. The effect of intraoperative heparin administered during total hip arthroplasty on the incidence of proximal deep vein thrombosis assessed by magnetic resonance venography.
    Westrich GH; Salvati EA; Sharrock N; Potter HG; Sánchez PM; Sculco TP
    J Arthroplasty; 2005 Jan; 20(1):42-50. PubMed ID: 15660059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraoperative heparin thromboembolic prophylaxis in primary total hip arthroplasty. A prospective, randomized, controlled, clinical trial.
    Huo MH; Salvati EA; Sharrock NE; Brien WW; Sculco TP; Pellicci PM; Mineo R; Go G
    Clin Orthop Relat Res; 1992 Jan; (274):35-46. PubMed ID: 1729021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and efficacy of intraoperative heparin in total hip arthroplasty.
    DiGiovanni CW; Restrepo A; González Della Valle AG; Sharrock NE; McCabe JP; Sculco TP; Pellicci PM; Salvati EA
    Clin Orthop Relat Res; 2000 Oct; (379):178-85. PubMed ID: 11039805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of D-dimer after total hip arthroplasty in patients with and without intraoperative heparin.
    Maezawa K; Nozawa M; Aritomi K; Kubota M; Shitoto K; Kurosawa H
    Arch Orthop Trauma Surg; 2008 Jan; 128(1):37-40. PubMed ID: 17522875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators.
    Hull RD; Pineo GF; Francis C; Bergqvist D; Fellenius C; Soderberg K; Holmqvist A; Mant M; Dear R; Baylis B; Mah A; Brant R
    Arch Intern Med; 2000 Jul; 160(14):2208-15. PubMed ID: 10904465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators.
    Hull RD; Pineo GF; Francis C; Bergqvist D; Fellenius C; Soderberg K; Holmqvist A; Mant M; Dear R; Baylis B; Mah A; Brant R
    Arch Intern Med; 2000 Jul; 160(14):2199-207. PubMed ID: 10904464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and time course of asymptomatic deep vein thrombosis with fondaparinux in patients undergoing total joint arthroplasty.
    Yamaguchi T; Hasegawa M; Niimi R; Sudo A
    Thromb Res; 2010 Oct; 126(4):e323-6. PubMed ID: 20451962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proximal deep vein thrombosis after hip replacement for oncologic indications.
    Nathan SS; Simmons KA; Lin PP; Hann LE; Morris CD; Athanasian EA; Boland PJ; Healey JH
    J Bone Joint Surg Am; 2006 May; 88(5):1066-70. PubMed ID: 16651581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep vein thrombosis after uncemented total hip replacement.
    Kim YH; Choi IY; Park MR; Park TS; Cho JL
    Bull Hosp Jt Dis; 1997; 56(3):133-9. PubMed ID: 9361912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis of deep-vein thrombosis in fractures below the knee: a prospective randomised controlled trial.
    Goel DP; Buckley R; deVries G; Abelseth G; Ni A; Gray R
    J Bone Joint Surg Br; 2009 Mar; 91(3):388-94. PubMed ID: 19258618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mechanical compression on the prevalence of proximal deep venous thrombosis as assessed by magnetic resonance venography.
    Ryan MG; Westrich GH; Potter HG; Sharrock N; Maun LM; Macaulay W; Katkin P; Sculco TP; Salvati EA
    J Bone Joint Surg Am; 2002 Nov; 84(11):1998-2004. PubMed ID: 12429761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gold Medal Forum Winner. Unfractionated heparin three times a day versus enoxaparin in the prevention of deep vein thrombosis in trauma patients.
    Arnold JD; Dart BW; Barker DE; Maxwell RA; Burkholder HC; Mejia VA; Smith PW; Longley JM
    Am Surg; 2010 Jun; 76(6):563-70. PubMed ID: 20583509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of intravenous fixed-dose heparin during total hip arthroplasty on the incidence of deep-vein thrombosis. A randomized, double-blind trial in patients operated on with epidural anesthesia and controlled hypotension.
    Sharrock NE; Brien WW; Salvati EA; Mineo R; Garvin K; Sculco TP
    J Bone Joint Surg Am; 1990 Dec; 72(10):1456-61. PubMed ID: 2254352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low-molecular-weight heparin for preventing deep-vein thrombosis after total joint arthroplasty].
    Yang G; Lu H; Gao J; Kou B; Yuan Y; Xu B
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):25-7. PubMed ID: 11831980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enoxaparin and heparin comparison of deep vein thrombosis prophylaxis in total hip replacement patients.
    Senaran H; Acaroğlu E; Ozdemir HM; Atilla B
    Arch Orthop Trauma Surg; 2006 Jan; 126(1):1-5. PubMed ID: 16333632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postthrombotic syndrome after asymptomatic deep vein thrombosis following total knee and hip arthroplasty.
    Lonner JH; Frank J; McGuire K; Lotke PA
    Am J Orthop (Belle Mead NJ); 2006 Oct; 35(10):469-72. PubMed ID: 17131737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 3,000 IU aXa of the low molecular weight heparin certoparin with 5,000 IU aXa in prevention of deep vein thrombosis after total hip replacement. German Thrombosis Study Group.
    Adolf J; Fritsche HM; Haas S; Hennig FF; Horbach T; Kastl S; Koppenhagen K; Michaelis HC; Rhamanzadeh R; Summa W; Wagner W; Weber U; Wolf H
    Int Angiol; 1999 Jun; 18(2):122-6. PubMed ID: 10424367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.